Last $11.02 USD
Change Today +0.02 / 0.18%
Volume 325.6K
MNTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for momenta pharmaceuticals inc (MNTA)

Year over year, Momenta Pharmaceuticals Inc. has seen revenues fall from $63.9M USD to $35.5M USD. This along with an increase in the cost of goods sold expense has led to a reduction in the bottom line from a loss of $58.6M USD to an even larger loss of $108.4M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Reclassified
Dec 31
2011
Reclassified
Dec 31
2012
Reclassified
Dec 31
2013
4 Year
Trend
Revenues116.8283.163.935.5
TOTAL REVENUES116.8283.163.935.5
Cost of Goods Sold51.717.417.734.3
GROSS PROFIT65.1265.646.21.2
Selling General & Admin Expenses, Total28.638.743.741.1
R&D Expenses--47.262.769.7
OTHER OPERATING EXPENSES, TOTAL28.685.9106.3110.8
OPERATING INCOME36.5179.7-60.1-109.6
Interest Expense-0.3-0.1----
Interest and Investment Income0.20.71.21.0
NET INTEREST EXPENSE-0.20.71.21.0
Other Non-Operating Income (Expenses)1.0--0.20.2
EBT, EXCLUDING UNUSUAL ITEMS37.3180.4-58.6-108.4
EBT, INCLUDING UNUSUAL ITEMS37.3180.4-58.6-108.4
Earnings from Continuing Operations37.3180.4-58.6-108.4
NET INCOME37.3180.4-58.6-108.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS37.3180.4-58.6-108.4
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS37.3180.4-58.6-108.4
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $11.02 USD +0.02

MNTA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natco Pharma Ltd 1,446 INR +14.55
OraSure Technologies Inc $8.35 USD -0.20
Pernix Therapeutics Holdings Inc $9.87 USD +0.72
SciClone Pharmaceuticals Inc $7.90 USD 0.00
Sucampo Pharmaceuticals Inc $8.31 USD -0.11
View Industry Companies
 

Industry Analysis

MNTA

Industry Average

Valuation MNTA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.5x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.